Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0152506002
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02537311 | JANSSEN INC | FINLIUS I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02537311 | JANSSEN INC | FINLIUS I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Approved | 02564882 | ACCORD HEALTHCARE INC | IMULDOSA IV | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Approved | 02564882 | ACCORD HEALTHCARE INC | IMULDOSA IV | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02553120 | JAMP PHARMA CORPORATION | JAMTEKI I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02553120 | JAMP PHARMA CORPORATION | JAMTEKI I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02554305 | FRESENIUS KABI CANADA LTD | OTULFI I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02554305 | FRESENIUS KABI CANADA LTD | OTULFI I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Approved | 02550520 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Approved | 02550520 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02459671 | JANSSEN INC | STELARA I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02459671 | JANSSEN INC | STELARA I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02550261 | CELLTRION INC. | STEQEYMA IV | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02550261 | CELLTRION INC. | STEQEYMA IV | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02544210 | AMGEN CANADA INC | WEZLANA I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02544210 | AMGEN CANADA INC | WEZLANA I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02562111 | BIOCON BIOLOGICS CANADA INC | YESINTEK I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02562111 | BIOCON BIOLOGICS CANADA INC | YESINTEK I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
Application information
Related information
Contact us
Version 4.0.4